NO | Imikhiqizo | Cas cha | Isicelo | Isikhombi sekhwalithi esemqoka | ||||
Ubumsulwa | Isikhungo | Ukungcola Okuthile | * Max1 | Ubumanzi | ||||
1 | I-FMOC-CYS (ACM) -OH | 86060-81-31-3 | I-Disfulfide Bond | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | I-FMOC-CYS (MMT) -OH | 177582-21-7 | I-Disfulfide Bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | I-FMOC-CYS (4-AllylButTrate) -OH | / | I-Disfulfide Bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | I-MPA (TRT) -OH | 27144-18-9 | Ukuphela kokulandelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | I-FMOC-Three (TBU) -OL | Ngo-189337-28-8 | I-Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | I-FMOC-D-ALF (PBF) -OH | Ngo-187618-60-6 | I-Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | FMoc-gly-gly-Oh | 35665-38-4 | Ibhayisikile | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | I-FMoc-gly-gly-Oh | 170941-79-4 | I-terligressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | I-FMoc-gly-gly-gly-Oh | / | Ibhayisikile | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | I-FMoc-Gly-ASP (TBU) -OH | / | Ibhayisikile | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | I-BOC-CYS (TRT) -OH | 21947-98-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | I-BOC-ALF (PBF) -OH | 200124-22-7-7 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-ala-Oh | 15761-38-3 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | I-BOC-D-PHE-OH | Ngo-18942-49-9 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | Boc-gly-oh | 4530-20-5-5 | Ukuphela kokulandelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | I-BOC-LYS (BOC) -OH.DCHA | 15098-69-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | I-Boc-Ser (TBU) -OH -OH | 7738-22-9 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | I-BOC-Thrist (TBU) -OH | 13734-40-2 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | I-BOC-D-ALA-OH | 7764-95-6 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | I-BOC-Met-OH | 2488-15-5 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | I-Boc-Tyr (TBU) -OH | 47375-34-8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | I-BOC-D-ALF (PDF) -OH | Ngo-187618-60-6 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | I-BOC-ASP (OTBU) -OH.DCHA | 1913/12/8 | Ukuphela kokulandelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | I-FMoc-Homoarg (PBF) -OH | 1159680-21-3 | Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | I-FMOC-ASP-OTBU | 129460-09-9 | Thymalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | FMoc-Tyr (Me) -OH | 77128-72-4 | Carbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | I-FMOC-ORN (BOC) -OH | 109425-55-0 | Atosiban Ompompipressin Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | I-FMOC-D-TRY (ET) -OH | 162502-65-6 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | I-FMOC-ASP (OALL) -OH | 146982-24-3 | Indlu ekhona | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | AC-NE-OH | 15891-49-3 | Indlu ekhona | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | I-FMOC-NE-OH | 77284-32-3 | Indlu ekhona Afamelanatide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | I-AC-Glu (OTBU) -OH | 84192-88-1 | I-arganiteline Acetyl octapeptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | AC-β-Ala-Ohcha | / | I-Acetyl Tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | FMoc-ß-Ala-Oh | 35737-10-1 | I-Acetyl Tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | I-FMOC-hyp (TBU) -OH | 122996-47-8 | Ikalinina | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | I-FMOC-THI-OH | 130309-35-2 | Ikalinina | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | I-FMOC-D-tic-OH | 130309-33-0 | Ikalinina | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | I-FMOC-OIC-OH | 130309-37-4 | Ikalinina | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | I-BOC-SAR-OH | 13734-36-6 | -Eralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | I-FMOC-SAR-OH | 77128-70-7-2 | -Eralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | I-FMoc-Tyr (SO3NA) -OH.h2O | 106864-37-3 | Uthambile | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | I-FMOC-D-ASP (OTBU) -OH | 112883-39 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | I-AC-SER (TBU) -OH -OH | 77285-09-7 | Afamelanatide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | I-Boc-Homocys (TRT) -OH | 201419-16-1 | Yehlisa | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | I-FMoc-homocys (TRT) -OH | 167015-23-8 | Yehlisa | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | I-FMOC-dab-Oh | 161420-87-7-7 | Uhlobo lwenyoko | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = Ubumsulwa obungaziwa
Enye inkomba:
- I-acetic acid: ≤0.02% (yonke imikhiqizo)
- I-Ethyl Acetate: ≤0.5% (yonke imikhiqizo)
- Utshwala: ≤0.5% (yonke imikhiqizo)
- I-MAX UNOKY Imprethent: I-FMOC-TRP (BOC) -OH (143824-78-6) ≤0.3%; Abanye ≤0.2%